United Capital Financial Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Sell
49,675
-4,980
-9% -$232K 0.01% 511
2025
Q4
$2.65M Sell
54,655
-201
-0.4% -$9.96K 0.02% 468
2025
Q3
$2.59M Sell
54,856
-5,955
-10% -$287K 0.02% 414
2025
Q2
$2.94M Sell
60,811
-5,186
-8% -$265K 0.02% 367
2025
Q1
$3.66M Sell
65,997
-2,643
-4% -$143K 0.03% 315
2024
Q4
$3.31M Sell
68,640
-2,734
-4% -$139K 0.03% 325
2024
Q3
$4.11M Sell
71,374
-2,873
-4% -$155K 0.03% 295
2024
Q2
$3.6M Sell
74,247
-5,514
-7% -$266K 0.03% 311
2024
Q1
$3.88M Sell
79,761
-24,368
-23% -$1.19M 0.03% 317
2023
Q4
$5.18M Sell
104,129
-165,656
-61% -$8.1M 0.04% 281
2023
Q3
$14.5M Sell
269,785
-2,378
-0.9% -$127K 0.09% 184
2023
Q2
$14.7M Buy
272,163
+1,260
+0.5% +$67.8K 0.08% 192
2023
Q1
$14.7M Buy
270,903
+232,649
+608% +$11.3M 0.08% 194
2022
Q4
$1.85M Sell
38,254
-1,468
-4% -$64.4K 0.01% 496
2022
Q3
$1.51M Buy
39,722
+1,183
+3% +$52.7K 0.01% 523
2022
Q2
$1.93M Buy
38,539
+1,146
+3% +$60.8K 0.01% 500
2022
Q1
$1.92M Buy
37,393
+1,181
+3% +$61K 0.01% 522
2021
Q4
$1.81M Sell
36,212
-2,425
-6% -$120K 0.01% 556
2021
Q3
$1.86M Buy
38,637
+816
+2% +$41.5K 0.01% 541
2021
Q2
$1.99M Sell
37,821
-931
-2% -$48.6K 0.01% 540
2021
Q1
$1.92M Buy
38,752
+1,012
+3% +$48.6K 0.01% 517
2020
Q4
$1.83M Buy
37,740
+743
+2% +$36.6K 0.01% 524
2020
Q3
$1.86M Buy
36,997
+1,446
+4% +$74.4K 0.01% 516
2020
Q2
$1.81M Buy
35,551
+351
+1% +$17.1K 0.01% 541
2020
Q1
$1.54M Sell
35,200
-7,803
-18% -$373K 0.01% 548
2019
Q4
$2.16M Buy
43,003
+8,062
+23% +$378K 0.01% 593
2019
Q3
$1.62M Sell
34,941
-13,617
-28% -$587K 0.01% 633
2019
Q2
$2.1M Buy
48,558
+6,406
+15% +$272K 0.01% 606
2019
Q1
$1.87M Sell
42,152
-6,111
-13% -$262K 0.01% 607
2018
Q4
$2.1M Buy
48,263
+3,860
+9% +$170K 0.02% 546
2018
Q3
$1.98M Buy
44,403
+2,313
+5% +$98.8K 0.01% 618
2018
Q2
$1.68M Buy
42,090
+1,663
+4% +$65.5K 0.01% 633
2018
Q1
$1.62M Buy
40,427
+2,859
+8% +$119K 0.01% 648
2017
Q4
$1.62M Buy
37,568
+2,040
+6% +$94.1K 0.01% 655
2017
Q3
$1.77M Sell
35,528
-832
-2% -$40.3K 0.02% 613
2017
Q2
$1.74M Buy
36,360
+933
+3% +$44.6K 0.02% 616
2017
Q1
$1.6M Sell
35,427
-205
-0.6% -$8.7K 0.01% 619
2016
Q4
$1.44M Sell
35,632
-3,943
-10% -$155K 0.01% 641
2016
Q3
$1.51M Sell
39,575
-3,724
-9% -$149K 0.01% 664
2016
Q2
$1.82M Sell
43,299
-19,384
-31% -$795K 0.02% 575
2016
Q1
$2.52M Sell
62,683
-56,486
-47% -$2.27M 0.03% 478
2015
Q4
$5.08M Sell
119,169
-7,219
-6% -$332K 0.06% 324
2015
Q3
$6M Buy
126,388
+14,570
+13% +$742K 0.07% 282
2015
Q2
$5.54M Buy
111,818
+17,150
+18% +$869K 0.06% 325
2015
Q1
$4.79M Buy
94,668
+17,934
+23% +$857K 0.06% 344
2014
Q4
$3.5M Buy
76,734
+26,807
+54% +$1.3M 0.05% 339
2014
Q3
$2.82M Sell
49,927
-1,905
-4% -$102K 0.05% 350
2014
Q2
$2.76M Buy
51,832
+2,364
+5% +$125K 0.05% 343
2014
Q1
$2.59M Buy
49,468
+28,209
+133% +$1.43M 0.06% 316
2013
Q4
$1.14M Sell
21,259
-38,078
-64% -$1.96M 0.04% 316
2013
Q3
$3M Buy
59,337
+10,499
+21% +$534K 0.1% 203
2013
Q2
$2.52M Buy
+48,838
New +$2.6M 0.07% 278

Other funds holding SNY

United Capital Financial Advisors's SNY Position: Q1 2026 in Review

United Capital Financial Advisors reduced its Sanofi (SNY) stake by 9.1% in Q1 2026, selling an estimated $232K and leaving 49,675 shares worth $2.39M. The position accounts for 0.01% of the portfolio, ranked #511.

United Capital Financial Advisors first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.7M in Q1 2023. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • United Capital Financial Advisors held 49,675 shares of Sanofi worth $2.39M as of Q1 2026.
  • United Capital Financial Advisors sold 4,980 Sanofi shares in Q1 2026, an estimated $232K.
  • Sanofi made up 0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #511 holding.
  • United Capital Financial Advisors first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Sanofi position peaked at $14.7M in Q1 2023.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.